Kyverna Therapeutics, Inc. (KYTX)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
7. 45
+0.01
+0.1344%
Pre Market
$
+0.15 +2.0134% 7. 60
347.71M Market Cap
- P/E Ratio
- Div Yield
874,266 Volume
- Eps
$ 7.44
Previous Close 
Want to track KYTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kyverna Therapeutics, Inc. (KYTX) Statistics
Valuation metrics
Market Cap 347.71M
Enterprise value 327.81M
Trailing P/E (ttm) -2.27
Forward P/E -
PEG ratio -2.74
Price/Sales (ttm) -
Price/Book (mrq) 2.3
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 999.04K
Average volume (90 days) 1.19M
Price summary
52-Week low 2.8
52-Week high 13.67
Beta -
50-Day moving average 8.37
200-Day moving average 8.7
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.61%
Return on equity -0.82%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.59
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.91
Total debt (mrq) -
Total Debt/Equity (mrq) 0.17
Current ratio (mrq) 8.15%
Book value per share (mrq) 3.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
